Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry.
Saliba F, Dharancy S, Salamé E, Conti F, Eyraud D, Radenne S, Antonini T, Guillaud O, Guguenheim J, Neau-Cransac M, Demartin E, Lasailly G, Duvoux C, Sobesky R, Coilly A, Tresson S, Cailliez V, Boillot O, Pageaux GP, Samuel D, Calmus Y, Dumortier J. Saliba F, et al. Among authors: pageaux gp. Liver Transpl. 2020 Nov;26(11):1465-1476. doi: 10.1002/lt.25879. Epub 2020 Oct 12. Liver Transpl. 2020. PMID: 32869469
Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.
Pageaux GP, Ducos J, Mondain AM, Costes V, Picot MC, Perrigault PF, Domergue J, Larrey D, Michel H. Pageaux GP, et al. Liver Transpl Surg. 1997 Sep;3(5):501-5. doi: 10.1002/lt.500030504. Liver Transpl Surg. 1997. PMID: 9346792 Free article.
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group.
Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G, Messner M, Launois B, Samuel D, Cherqui D, Pageaux G, Bernard PH, Calmus Y, Zarski JP, Miguet JP, Chaput JC. Poynard T, et al. J Hepatol. 1999 Jun;30(6):1130-7. doi: 10.1016/s0168-8278(99)80269-4. J Hepatol. 1999. PMID: 10406193 Clinical Trial.
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, Scudamore CH, Cuervas-Mons V, Metselaar HJ, Prestele H, Girault D. Calmus Y, et al. Among authors: pageaux gp. Liver Transpl. 2002 Feb;8(2):123-31. doi: 10.1053/jlts.2002.30882. Liver Transpl. 2002. PMID: 11862588 Free article. Clinical Trial.
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C. Decaens T, et al. Among authors: pageaux gp. Liver Transpl. 2005 Jul;11(7):767-775. doi: 10.1002/lt.20418. Liver Transpl. 2005. PMID: 15973710 Free article.
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Sulpice L, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Cherqui D, Duvoux C. Decaens T, et al. Among authors: pageaux gp. Liver Transpl. 2006 Dec;12(12):1761-9. doi: 10.1002/lt.20884. Liver Transpl. 2006. PMID: 16964590 Free article.
289 results